Literature DB >> 11588064

Screening for prostate cancer in the UK. Seems to be creeping in by the back door.

J L Donovan, S J Frankel, D E Neal, F C Hamdy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11588064      PMCID： PMC1121324          DOI： 10.1136/bmj.323.7316.763

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  How policy informs the evidence.

Authors:  G Davey Smith; S Ebrahim; S Frankel
Journal:  BMJ       Date:  2001-01-27

Review 2.  Prostate cancer: to screen or not to screen?

Authors:  D E Neal; J L Donovan
Journal:  Lancet Oncol       Date:  2000-09       Impact factor: 41.316

3.  Preferences of elderly men for prostate-specific antigen screening and the impact of informed consent.

Authors:  A M Wolf; J B Schorling
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1998-05       Impact factor: 6.053

Review 4.  Diagnosis, management and screening of early localised prostate cancer.

Authors:  S Selley; J Donovan; A Faulkner; J Coast; D Gillatt
Journal:  Health Technol Assess       Date:  1997       Impact factor: 4.014

5.  Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-1998.

Authors:  A Majeed; P Babb; J Jones; M Quinn
Journal:  BJU Int       Date:  2000-06       Impact factor: 5.588

6.  A randomized controlled trial of shared decision making for prostate cancer screening.

Authors:  R J Volk; A R Cass; S J Spann
Journal:  Arch Fam Med       Date:  1999 Jul-Aug

Review 7.  Decision aids for patients facing health treatment or screening decisions: systematic review.

Authors:  A M O'Connor; A Rostom; V Fiset; J Tetroe; V Entwistle; H Llewellyn-Thomas; M Holmes-Rovner; M Barry; J Jones
Journal:  BMJ       Date:  1999-09-18

8.  Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.

Authors:  F J Fowler; M McNaughton Collins; P C Albertsen; A Zietman; D B Elliott; M J Barry
Journal:  JAMA       Date:  2000-06-28       Impact factor: 56.272

9.  The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.

Authors:  A B Flood; J E Wennberg; R F Nease; F J Fowler; J Ding; L M Hynes
Journal:  J Gen Intern Med       Date:  1996-06       Impact factor: 5.128

Review 10.  A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team.

Authors:  J H Wasson; C C Cushman; R C Bruskewitz; B Littenberg; A G Mulley; J E Wennberg
Journal:  Arch Fam Med       Date:  1993-05
View more
  8 in total

1.  Demand for prostate specific antigen testing in primary care. Screening through back passage as well as back door?

Authors:  Keith Hopcroft
Journal:  BMJ       Date:  2002-03-02

2.  The discomfort of patient power.

Authors:  Richard Smith
Journal:  BMJ       Date:  2002-03-02

3.  "Well, have I got cancer or haven't I?" The psycho-social issues for women diagnosed with ductal carcinoma in situ.

Authors:  Simone De Morgan; Sally Redman; Kate J White; Burcu Cakir; John Boyages
Journal:  Health Expect       Date:  2002-12       Impact factor: 3.377

4.  Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity.

Authors:  Andrew J Coldman; Norman Phillips; Thomas A Pickles
Journal:  CMAJ       Date:  2003-01-07       Impact factor: 8.262

5.  Why men with prostate cancer want wider access to prostate specific antigen testing: qualitative study.

Authors:  Alison Chapple; Sue Ziebland; Sasha Shepperd; Rachel Miller; Andrew Herxheimer; Ann McPherson
Journal:  BMJ       Date:  2002-10-05

6.  Feasibility of familial PSA screening: psychosocial issues and screening adherence.

Authors:  J Sweetman; M Watson; A Norman; Z Bunstead; P Hopwood; J Melia; S Moss; R Eeles; D Dearnaley; C Moynihan
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

7.  Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.

Authors:  Frances J Drummond; Anne-Elie Carsin; Linda Sharp; Harry Comber
Journal:  BMC Fam Pract       Date:  2009-01-12       Impact factor: 2.497

8.  Effectiveness and cost-effectiveness of prognostic markers in prostate cancer.

Authors:  N W Calvert; A B Morgan; J W F Catto; F C Hamdy; R L Akehurst; P Mouncey; S Paisley
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.